Skip to main content
Have a personal or library account? Click to login
Effects of lactoferrin and progesterone on the endometriotic lesion in a female rat model Cover

Effects of lactoferrin and progesterone on the endometriotic lesion in a female rat model

Open Access
|Jun 2026

References

  1. Legrand D, Elass E, Carpentier M, Mazurier J. Lactoferrin: a modülatör of immune and inflammatory responses. Cell Mol Life Sci. 2005; 62(22):2549–59.
  2. Spear GT, Kendrick SR, Chen HY, Thomas TT, Bahk M, Balderas R, et al. Multiplex immunoassay of lower genital tract mucosal fluid from women attending an urban STD clinic shows broadly increased IL1ß and lactoferrin. PLoS One. 2011; 6:e19560. doi: 10.1371/journal.pone.0019560
  3. Rosa L, Cutone A, Lepanto MS, Paesano R, Valenti P. Lactoferrin: a natural glycoprotein involved in iron and inflammatory homeostasis. Int J Mol Sci. 1985; 18:1985. doi: 10.3390/ijms18091985
  4. Bulun SE, Yilmaz BD, Sison C, Miyazaki K, Bernardi L, Liu S, et al. Endometriosis. Endocr Rev. 2019; 40:1048–79.
  5. Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021; 397:839–52.
  6. Tang HC, Lin TC, Wu MH, Tsai SJ. Progesterone resistance in endometriosis: a pathophysiological perspective and potential treatment alternatives. Reprod Med Biol. 2024; 23:e12588. doi: 10.1002/rmb2.12588
  7. Yu Q, Zhang S, Li H, Wang P, Zvolanek M, Ren X, et al. Dienogest for treatment of endometriosis in women: a 28-weeks, open-label, extension study. J Womens Health (Larchmt). 2019; 28:170–7.
  8. Ureyen Ozdemir E, Adali E, Islimye Taskin M, Yavasoglu A, Aktug H, Oltulu F, et al. Effects of ranibizumab and zoledronic acid on endometriosis in a rat model. Arch Gynecol Obstet. 2022; 306:1399–405.
  9. Li S, Liu M, Ma H, Jin Q, Ma Y, Wang C, et al. Ameliorative effect of recombinant human lactoferrin on the premature ovarian failure in rats after cyclophosphamide treatments. J Ovarian Res. 2021; 14:17.
  10. Artym J, Zimecki M. Antimicrobial and prebiotic activity of lactoferrin in the female reproductive tract: a comprehensive review. Biomedicines. 2021; 9:1940. doi: 10.3390/biomedicines9121940
  11. Farley J, Loup D, Nelson M, Mitchell A, Esplund G, Macri C, et al. Neoplastic transformation of the endocervix associated with downregulation of lactoferrin expression. Mol Carcinog. 1997; 20:240–50.
  12. Polak G, Wertel I, Tarkowski R, Morawska D, Kotarski J. Decreased lactoferrin levels in peritoneal fluid of women with minimal endometriosis. Eur J Obstet Gynecol Reprod Biol. 2007; 131:93–6.
  13. Mori-Yamanaka K, Kimura F, Nakamura A, Hanada T, Kitazawa J, Morimune A, et al. Exploratory study of serum lactoferrin and anti-lactoferrin antibody concentrations in patients with endometriosis. Tohoku J Exp Med. 2023; 259:135–42.
  14. Cora MC, Kooistra L, Travlos G. Vaginal cytology of the laboratory rat and mouse: review and criteria for the staging of the estrous cycle using stained vaginal smears. Toxicol Pathol. 2015; 43:776–93.
  15. Vernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril. 1985; 44:684–94.
  16. Demirel MA, Suntar I, Ilhan M, Keles H, Kupeli Akkol E. Experimental endometriosis remission in rats treated with Achillea biebersteinii Afan: histopathological evaluation and determination of cytokine levels. Eur J Obstet Gynecol Reprod Biol. 2014; 175:172–7.
  17. Luna-Luna LG. Manual of histologic staining methods of thearmed forces institute of pathology. 3rd ed. New York, USA: Blakiston Division, McGraw-Hill; 1968.
  18. Yalinbas-Kaya B, Tureyen A, Cesur S, Zemheri-Navruz F, Demirel HH, Ince S. Iristectorin A ameliorates cisplatin-induced hepatorenal injury in mice through modulation of the Nrf2/HO-1 signaling pathway. J Biochem Mol Toxicol. 2025; 39:e70136. doi: 10.1002/jbt.70136
  19. Zhou X, Xu W, Tang X, Luo L, Tu J, Zhang Ch, et al. Fecal lactoferrin in discriminating inflammatora bowel disease from irritable bowel syndrome: a diagnostic meta-analysis. BMC Gastroenterol. 2014; 14:121. doi: 10.1186/1471-230X-14-121
  20. Satie AP, Mazaud-Guittot S, Seif I, Mahé D, He Z, Jouve G, et al. Excess type I interferon signaling in the mouse seminiferous tubules leads to germ cell loss and sterility. J Biol Chem. 2011; 286:23280–95.
  21. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004; 37:277–85.
  22. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005; 38:1103–11.
  23. Smolarz B, Szyłło K, Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (review of literature). Int J Mol Sci. 2021; 22:10554. doi: 10.3390/ijms221910554
  24. Zhang P, Wang G. Progesterone resistance in endometriosis: current evidence and putative mechanisms. Int J Mol Sci. 2023; 24:6992. doi: 10.3390/ijms24086992
  25. McMaster MT, Teng CT, Dey SK, Andrews GK. Lactoferrin in the mouse uterus: analyses of the preimplantation period and regulation by ovarian steroids. Mol Endocrinol. 1992; 6:101–11.
  26. Walmer DK, Wrona MA, Hughes CL, Nelson KG. Lactoferrin expression in the mouse reproductive tract during the natural estrous cycle: correlation with circulating estradiol and progesterone. Endocrinol. 1992; 131:1458–66.
  27. Teng CT, Gladwell W, Beard C, Walmer D, Teng CS, Brenner R. Lactoferrin gene expression is estrogen responsive in human and rhesus monkey endometrium. Mol Hum Reprod. 2002; 8:58–67.
  28. Giuffrè G, Arena F, Scarfì R, Simone A, Todaro P, Tuccari G. Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival. Oncol Rep. 2006; 16:257–63.
  29. Walmer DK, Padin CJ, Wrona MA, Healy BE, Bentley RC, Tsao MS, et al. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein. Cancer Res. 1995; 55:1168–75.
  30. Bedaiwy MA, Dahoud W, Skomorovska-Prokvolit Y, Yi L, Liu JH, Falcone T, et al. Abundance and localization of progesterone receptor isoforms in endometrium in women with and without endometriosis and in peritoneal and ovarian endometriotic implants. Reprod Sci. 2015; 22:1153–61.
  31. Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics. 2006; 1:106–11.
  32. Patel BG, Rudnicki M, Yu J, Shu Y, Taylor RN. Progesterone resistance in endometriosis: origins, consequences and interventions. Acta Obst Gynecol Scand. 2017; 96:623–32.
  33. Shen F, Yan C, Liu M, Feng Y, Chen Y. Decreased expression of mucin-1 in endometriosis endometrium correlated with progesterone receptor B involved in infertility. Arch Gynecol Obstet. 2015; 291:439–45.
  34. Apparao KB, Murray MJ, Fritz MA, Meyer WR, Chambers AF, Truong PR, et al. Osteopontin and its receptor alphavbeta(3) integrin are coexpressed in the human endometrium during the menstrual cycle but regulated differentially. J Clin Endocrinol Metab. 2001; 86:4991–5000.
  35. Takamoto N, Zhao B, Tsai SY, DeMayo FJ. Identification of Indian hedgehog as a progesterone-responsive gene in the murine uterus. Mol Endocrinol. 2002; 16:2338–48.
  36. Stavreus-Evers A, Mandelin E, Koistinen R, Aghajanova L, Hovatta O, Seppälä M. Glycodelin is present in pinopodes of receptive-phase human endometrium and is associated with down-regulation of progesterone receptor B. Fertil Steril. 2006; 85:1803–11.
  37. Wang H, Wang B, Wu M, Lu J, Duan P. Targeting osteopontin alleviates endometriosis and inflammation by inhibiting the RhoA/ROS axis and achieves non-invasive in vitro detection via menstrual blood. Hum Reprod. 2024; 39:1057–71.
  38. Yami HA, Tahmoorespur M, Javadmanesh A, Tazarghi A, Sekhavati MH. The immunomodulatory effects of lactoferrin and its derived peptides on NF-κB signaling pathway: a systematic review and meta-analysis. Immun Inflamm Dis. 2023; 11:e972. doi: 10.1002/iid3.972
  39. Matteo M, Cicinelli E, Neri M, Carrubba R, Carpagnano FA, Romeo F, et al. Pro-inflammatory M1/Th1 type immune network and increased expression of TSG-6 in the eutopic endometrium from women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2017; 218:99–105.
  40. Pan Y, Liu Z, Wang Y, Zhang L, Chua N, Dai L, et al. Evaluation of the anti-inflammatory and anti-oxidative effects of therapeutic human lactoferrin fragments. Front Bioeng Biotechnol. 2021; 9:779018. doi: 10.3389/fbioe.2021.779018
  41. Machairiotis N, Vasilakaki S, Thomakos N. Inflammatory mediators and pain in endometriosis: a systematic review. Biomedicines. 2021; 9:54. doi: 10.3390/biomedicines9010054
  42. Lu D, Song H, Shi G. Anti-TNF-α treatment for pelvic pain associated with endometriosis. Cochrane Database Syst Rev. 2013; 2013:CD008088. doi: 10.1002/14651858.CD008088.pub3
  43. Yu J, Berga SL, Zou E, Schrepf AD, Clauw DJ, As-Sanie S, et al. Neurotrophins and their receptors, novel therapeutic targets for pelvic pain in endometriosis, are coordinately regulated by IL-1β via the JNK signaling pathway. Am J Pathol. 2023; 193:1046–58.
DOI: https://doi.org/10.2478/abm-2026-0019 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 161 - 169
Published on: Jun 30, 2026
In partnership with: Paradigm Publishing Services

© 2026 İrem Şenyuva, Duygu Baki Acar, Hasan Hüseyin Demirel Bayat, Funda Karabağ, Ece Tunç, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution 4.0 License.